The Mitra Project

MGM-15

MGM-15 · CAS n/a

Synthetic analog

Formula

C₂₄H₃₂N₂O₅

Molecular Weight

428.53 g/mol

Abundance in Leaf

Synthetic

Last Reviewed

2026-03-12

What Is MGM-15?

MGM-15 is a synthetic analog of mitragynine designed to enhance G-protein signalling while maintaining low beta-arrestin recruitment. It acts as a partial agonist at the mu-opioid receptor with moderate affinity (Ki ~35 nM). Preclinical data shows antinociception without significant respiratory depression at equianalgesic doses. MGM-15 is a tool compound used in pharmacological research to study biased agonism — it is not found in kratom or consumer products.

Dose-Dependent Effects

Receptor Activity

ReceptorKi (nM)Activity TypeWhat This Means
Mu-opioid (MOR)~35Partial agonist (G-protein biased)Moderate affinity MOR partial agonist engineered for maximal G-protein bias over beta-arrestin recruitment.

Safety & Adverse Effects

Research status

MGM-15 is a synthetic research compound. All pharmacological data is preclinical. Not present in any consumer product.

Source: Váradi et al. 2016

Drug Interactions

COA Connection

Appears on Certificates of Analysis as: N/A. Graded under Not measured on COAs (Synthetic research compound).

View graded products

Cited Literature

[1]

Váradi A, Marrone GF, Palmer TC, et al. (2016). Mitragynine/corynantheidine pseudoindoxyls as opioid analgesics with mu agonism and delta antagonism, which do not recruit β-arrestin-2. J Am Chem Soc.

DOI: 10.1021/jacs.6b00360